CAPR - Capricor Therapeutics GAAP EPS of -$0.31 misses by $0.20 revenue of $4.91M misses by $4.79M
2024-05-13 16:13:33 ET
More on Capricor Therapeutics
- Capricor Therapeutics, Inc. (CAPR) Q4 2023 Earnings Call Transcript
- Capricor Therapeutics Q1 2024 Earnings Preview
- Capricor scales up manufacturing capacity for DMD therapy
- Seeking Alpha’s Quant Rating on Capricor Therapeutics
- Historical earnings data for Capricor Therapeutics